Zata Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 5

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 2

Loading Chart...

2 inventors (with patents filed for the assignee):

David R Tabatadze (5 out of 9 patents)

Ivan Yanachkov (3 out of 5 patents)

5 patents: Sort by Forward Citations

1. 12297225 - Detection method for natural and modified small nucleic acids (2025-05-13),

2. 11566042 - Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds (2023-01-31),

3. 10738005 - Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the same (2020-08-11),

4. 10723755 - Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds (2020-07-28),

5. 10173976 - Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the same (2019-01-08),

Company Overview

Zata Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to developing innovative therapies for various diseases. With a focus on research and development, Zata Pharmaceuticals strives to improve patient outcomes and quality of life. Our team of experts is committed to delivering high-quality, safe, and effective medications to meet the needs of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

5 Patents

#42 in Worcester, MA

#2,897 in Massachusetts

#51,708 in US

Worcester, MA, United States of America

Zata Pharmaceuticals, Inc.

Forward Citations = 2

2 inventors:

David R Tabatadze (5 out of 9 patents)

Ivan Yanachkov (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Zata Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/zata-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]